Lario Therapeutics
PrivateLast Round
Grant
Feb 19, 2026
Total Funding Raised
$8.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lario Therapeutics operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Grant round in February 2026.
Lario Therapeutics is a biopharmaceutical company that develops first-in-class precision medicines for severe neurological disorders, including epileptic conditions and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lario Therapeutics Comparables
Compare Lario Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autifony Therapeutics Limited | 77% | |
| H. Lundbeck A/S | 72% | |
| Muna Therapeutics | 72% |
For institutional investors. Book with your work email.
Lario Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 19, 2026 | ||||
| Grant | Jul 22, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lario Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Seed |
| AXXAM Family Office | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Received $2M from The Michael J. Fox Foundation and Wellcome Trust.
- Jan 21, 2026
Monthly visitors increased 113% MoM.
For institutional investors. Book with your work email.
Lario Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lario Therapeutics's valuation, stock price, and market status.
Is Lario Therapeutics a public or private company?
Lario Therapeutics is a private company.
What is the current stock price of Lario Therapeutics?
Lario Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lario Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lario Therapeutics worth (valuation)?
Valuation information for Lario Therapeutics is not publicly available.
Can I buy Lario Therapeutics stock?
Lario Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lario Therapeutics's last funding round?
Lario Therapeutics's most recent funding round was Grant on February 19, 2026.
Who are the main investors in Lario Therapeutics?
Key investors in Lario Therapeutics include Epidarex Capital, AXXAM Family Office, The Michael J. Fox Foundation for Parkinson's Research, Wellcome Trust.
Will Lario Therapeutics IPO soon?
No public IPO plans have been announced for Lario Therapeutics.
How can I track Lario Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lario Therapeutics's shares on secondary markets.